ATPGQ yields 1000000.00% · PFE yields 6.13%● Live data
📍 ATPGQ pulled ahead of the other in Year 1
Combined, ATPGQ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATPGQ + PFE for your $10,000?
On October 12, 2021, ATP Oil & Gas Corp. went out of business as per its Chapter 7 liquidation filing under bankruptcy. ATP Oil & Gas Corp. engages in the acquisition, development, and production of oil and natural gas properties primarily in the Gulf of Mexico and the United Kingdom sector of the North Sea. The company also has interests in three deepwater licenses in the Mediterranean Sea off the coast of Israel. As of December 31, 2011, it had estimated net proved reserves of 118.9 million barrels of crude oil equivalent (MMBoe), of which approximately 75.9 MMBoe were in the Gulf of Mexico and 42.9 MMBoe were in the North Sea. The company's reserves comprised approximately 78.6 million barrels of crude oil or other liquid hydrocarbons and 241.5 billion cubic feet of natural gas. It also owned leasehold and other interests in 38 offshore blocks and 49 wells comprising 23 subsea wells in the Gulf of Mexico, as well as had interests in 13 blocks and 2 company-operated subsea wells in the North Sea. ATP Oil & Gas Corporation was founded in 1991 and is headquartered in Houston, Texas.
Full ATPGQ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.